Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Einfacher Volltextzugriff von (fast) überall
Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...
Open Access
    Datensatz exportieren als...
  • BibTeX
Amantadine ER (Gocovri ® ) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's Disease
Frontiers in neurology, 2021-03, Vol.12, p.645706-645706
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson's disease
NPJ Parkinson's Disease, 2022-03, Vol.8 (1), p.29-29, Article 29
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Potential utility of amantadine DR/ER in persons with Parkinson’s disease meeting 5-2-1 criteria for device aided therapy
Clinical parkinsonism & related disorders, 2022-01, Vol.6, p.100123-100123, Article 100123
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Extended-release amantadine for OFF-related dystonia in Parkinson's disease
Parkinsonism & related disorders, 2024-05, Vol.122, p.106088-106088, Article 106088
2024
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM‐II Open Label Study
PM & R, 2018-10, Vol.10 (10), p.993-1003
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and Dyskinesia
Neurology and therapy, 2021-12, Vol.10 (2), p.739-751
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia
Frontiers in neurology, 2022-10, Vol.13, p.846126-846126
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions
Current medical research and opinion, 2014-11, Vol.30 (11), p.2255-2265
2014
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
BMC neurology, 2016-06, Vol.16 (1), p.89-89, Article 89
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Dextromethorphan/Quinidine for Pseudobulbar Affect Following Stroke: Safety and Effectiveness in the PRISM II Trial
PM & R, 2019-01, Vol.11 (1), p.17-24
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Safety and Tolerability of Dextromethorphan/Quinidine in Older Patients
The American journal of geriatric psychiatry, 2017-03, Vol.25 (3), p.S142-S142
2017
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
BMC neurology, 2016-09, Vol.16 (1), p.160-160, Article 160
2016
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
An Open-Label Study to Assess Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect (PBA) in Dementia, Stroke and Traumatic Brain Injury: PRISM II Combined Cohort Results for Patients Aged ≥65 Years
The American journal of geriatric psychiatry, 2016-03, Vol.24 (3), p.S146-S147
2016
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Persistence of Effect of Dextromethorphan Hydrobromide/Quinidine Sulfate (DM/Q) for Pseudobulbar Affect (PBA): Results from a 12-Week Open-Label Extension (OLE) Study (P6.313)
Neurology, 2017-04, Vol.88 (16_supplement)
2017
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
199 Cardiac Safety and QTc Intervals With DM/Q Treatment for Pseudobulbar Affect: A Review of Clinical Trial Data
CNS spectrums, 2018-02, Vol.23 (1), p.112-112
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Huperzine A suppresses absence seizures in the genetic absence epilepsy rat from Strasbourg ( GAERS ) model of genetic generalized epilepsy with absence seizures
Epilepsia open, 2024-08
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Dextromethorphan/Quinidine Improved Symptoms of Pseudobulbar Affect Irrespective of Concomitant Antidepressant Use (P6.210)
Neurology, 2017-04, Vol.88 (16_supplement)
2017
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Poster Number: NR 29 - Safety and Tolerability of Dextromethorphan/Quinidine in Older Patients
The American journal of geriatric psychiatry, 2017-03, Vol.25 (3), p.S142-S142
2017
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Poster Number: NR 15 - An Open-Label Study to Assess Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect (PBA) in Dementia, Stroke and Traumatic Brain Injury: PRISM II Combined Cohort Results for Patients Aged ≥65 Years
The American journal of geriatric psychiatry, 2016-03, Vol.24 (3), p.S146-S147
2016
Volltextzugriff (PDF)
1 – 19 von 19
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen